2024, Number 6
<< Back Next >>
Rev Fac Med UNAM 2024; 67 (6)
Cerebral Aneurysm Clipping in a Patient with Polycystic Kidney Disease Prior to Kidney Transplant. A Case Report
Prado HEN, Ferrufino MBR, Ferrufino MMA, Vázquez NJR, Vargas DCI
Language: Spanish
References: 20
Page: 17-27
PDF size: 247.46 Kb.
ABSTRACT
The study of aneurysms is of special interest in the field of
medicine. Diagnosis can be very challenging and is based on
clinical presentation and various imaging studies, such as magnetic
resonance angiography, which can identify aneurysms as
small as 3 mm. Aneurysms develop early when intravascular
pressure exceeds the resistance capacity of the vascular wall.
The promoting and triggering factors that alter the shape and
function of the vascular wall are diverse. Treatment of arterial
aneurysms has been limited to surgical intervention. Intervention
options include endovascular embolization and surgical
clipping, the latter as presented in this case.
REFERENCES
Rozenfeld MN, Ansari SA, Shaibani A, Russell EJ, MohanP, Hurley MC. Should patients with autosomal dominantpolycystic kidney disease be screened for cerebral aneurysms?Neuroradiol. 2019;35:3-9.
Ko BL, U. Nerissa, American Heart Association/AmericanStroke Association. 2023 Guideline for the managementof patients with aneurysmal subarachnoid hemorrhage.Stroke. 2023;54. doi: 10.1161/STR.0000000000000436.
Bizjak Ž, Špiclin Ž. A systematic review of deep-learningmethods for intracranial aneurysm detection in CT angiography.Biomedicines. 2023;11:2921.
Pontes FG, da Silva EMK, Baptista-Silva JCC, VasconcelosV. Treatments for unruptured intracranial aneurysms. CochraneDatabase Syst Rev. 2021;(5).
Xu Z, Rui YN, Hagan JP. Intracranial aneurysms: pathology,genetics, and molecular mechanisms. NeuromolecularMed. 2019 Dec;21(4):325-343. doi: 10.1007/s12017-019-08537-7.
Mocco J, Brown RD Jr. Aneurysm morphology and predictionof rupture: an international study of unruptured intracranialaneurysms analysis. Neurosurgery. 2018;82:491-496.
Rinkel GE, Ruigrok M. Preventive screening for intracranialaneurysms. Int J Stroke. 2022;17(1):30-36.
Iceta Lizárraga A, Barajas de Frutos D. Enfermedades quísticasrenales. Protoc diagn ter pediatr. 2014;1:191-206.
Iceta Lizárraga A, Hualde I, Nadal I. Enfermedades quísticasrenales. Protocolos Diagnóstico Terapéuticos de laAEP: Nefrología Pediátrica. 2018:208-220.
Nishimura S, Suzuki M, Mizoi K, Yoshimoto T. Multiplecerebral aneurysms associated with aortitis syndrome.Neurol Med Chir (Tokyo). 2014;34:821-824.
Montaña A, Patiño N, Larrate C. Update on polycystickidney disease. Rev Fac Med. 2018;66(1):107-116.
Martínez Jiménez V, Ramos Carrasco F. Utility of a consultationon hereditary kidney diseases: a different approachbased on the family tree. Nefrología. 2016;36(3):217-221.
Aguilar-Garay VA, Fabian-Mijangos W, Moreno-RojasJC, Hernández-López D. Renal artery aneurysm: literaturereview and case report. Rev Mex Angiol. 2021;49(4):133-138.
Walker YX, Marlais M. Should we screen for intracranialaneurysms in children with autosomal dominant polycystickidney disease? Pediatr Nephrol. 2023;38:77-85.
Yoo DJ, Agodoa L, Yuan CM. Risk of intracranial hemorrhageassociated with autosomal dominant polycystickidney disease in patients with end-stage renal disease.BMC Nephrol. 2014;15:39.
Milet LE. Historia natural de los aneurismas intracraneales.Aneurismas sin ruptura. Rev Argent Neuroc. 2006;20:19.
Kataoka H, Akagawa H, Yoshida R. Impact of kidneyfunction and kidney volume on intracranial aneurysmsin patients with autosomal dominant polycystic kidneydisease. Sci Rep. 2022;12:18056.
Castillón Benavides O, Tena Suck ML. Hemorragia subaracnoideapor ruptura de aneurismas múltiples en poliquistosisrenal autosómica dominante del adulto. ArchNeurocien (Mex). 2018;15(1):56-60.
García Zambrano W, Sempertegui Rojas C. Aneurismasintracraneales múltiples: presentación de un caso y revisiónde la literatura. Arch Neurocien (Mex). 2018;15(1):56-60.
Zühlsdorf T, Hörtnagel K, Mulahasanovic L, Grauer OM,Kümpers P, Wiendl H, Meuth SG. A novel PKD1 mutationassociated with autosomal dominant kidney diseaseand cerebral cavernous malformation. Front Neurol.2018;9:383. doi: 10.3389/fneur.2018.00383.
Full text